- Lobbying
- life AND technologies
Lobbying Arrangements Results for 'Life Technologies'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Lobbying for research funding. |
Active Life Technologies
|
J M BURKMAN & ASSOCIATES | |||
Details Office of Health Affairs spending in Department of Homeland Security account H.R. 1 and related spending bills for FY2011 |
Life Technologies Corporation
|
Cardinal Point Parnters | |||
Details Policy issues related to regulation of life science research products by FDA |
Life Technologies Corporation
|
SIDLEY AUSTIN LLP | |||
Details Education and understanding of capabilities of emergency respirators and continuity of operations |
Immediate Response Technologies
|
CarterMcClean LLC | |||
Details Defense Appropriations Bill HR 3326 |
Ultimate Survival Technologies
|
MR. HUGH MCGILLICUDDY | |||
Details Assitance with issues relating to the environment and fish life |
GLO-FISH-YORKTOWN TECHNOLOGIES
|
Ben Barnes Group LP | |||
Details Issues related to funding for battery research and procurement. |
mPhase Technologies, Inc.
|
PATTON BOGGS LLP | |||
Details Traumatic Brain Injury Prevention |
PreActive Technologies, Inc.
|
The Conafay Group, LLC | |||
Details Food safety law implementation PL 111-353 with emphasis on those titles related to the inspection and testing of imported and domestic food ingredients. Federal meat, poultry, egg and food inspect... |
LIFE TECHNOLOGIES
|
POLICY DIRECTIONS INC. | |||
Details HR 5893 / S. 2321 - provisions related to forensic DNA funding HR 1105 / S. 499 -- Debbie Smith DNA Backlog Elimination Reauthorization Act |
Thermo Fisher Scientific Inc.
|
Gordon Thomas Honeywell Governmental Affairs | |||
Details Issues pertaining to breast cancer |
Life Medical Technologies, Inc.
|
BROWNSTEIN HYATT FARBER SCHRECK, LLP | |||
Details in vitro diagnostics, clinical laboratories, digital health regulation |
Life Technologies/Thermo Fisher
|
Goldbug Strategies LLC | |||
Details -Implementation of the Orphan Drug Act of 1938 (Pub. L. No. 97-414) and orphan drug development -Federal funding and regulation of innovative genetic technologies - FDA User Fee Reauthorization Act... |
Wave Life Sciences
|
FOLEY HOAG LLP | |||
Details Gather ideas/perfom research for development of synthetic biology legislation. Met with congressional staff to discuss proposed legislation to support synthetic biology research and biosecurity. |
LIFE TECHNOLOGIES CORPORATION
|
HOLLAND & KNIGHT LLP | |||
Details Establishment of a pilot study to assess the effectiveness of a daily application of clinically-proven alcohol-based nasal antiseptic in reducing infection risk and enhancing warfighter operational... |
Global Life Technologies
|
CURA STRATEGIES | |||
Details Issues related to international taxation, and research and development expensing. |
Agilent Technologies, Inc.
|
MCDERMOTT WILL & EMERY LLP | |||
Details DOD RDT&E Department of Defense Appropriations Act, FY 2012. National Defense Authorization Act for Fiscal Year FY 2012. |
Clean Earth Technologies, LLC
Chemical and biological detection and mitigation; night vision technologies; life sciences |
Stapleton & Associates, LLC | |||
Details Procurement of Client-specific Technologies Procurement of Client-Specific Technologies |
Praemittias Systems LLC
|
Miller Group International LLC | |||
Details NOTE FROM LIFE TECHNOLOGIES CORPORATION: THIS IS A TERMINATION REPORT FOR APPLIED BIOSYSTEMS INC. LIFE TECHNOLOGIES CORPORATION WAS CREATED FROM THE MERGER OF INVITROGEN CORPORATION AND APPLIED B... |
APPLIED BIOSYSTEMS
|
in-house lobbying | |||
Details FY 09 Dept of Defense (RDT&E -- Medical Research) FY 09 Military Quality of Life Approps (VA Medical Reserach) |
PALOMAR MEDICAL TECHNOLOGIES
|
NATIONAL GROUP LLP | |||
Details Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act, FY 2014; Provisions regarding National Institutes of Health funding. H.R. 3005: Medical Test... |
LIFE TECHNOLOGIES CORPORATION
|
in-house lobbying | |||
Details Grant or appropriation for device development |
Life-Pack Technologies
Development of fire safety devices for firefighters and civilians |
Stradley, Ronon, Stevens & Young, LLP | |||
Details Pandemic preparedness. Pandemic preparedness and health care workforce protection. Issues related to pandemic preparedness and bioterrorism. |
Safe Life Corporation
|
PATTON BOGGS LLP | |||
Details No Bill#, Genomics and Personalized Medicine Act, Personalized medicine Health information technology Regulation and reimbursement of laboratory developed tests Regulatory scienceNo Bill#, BETTER P... |
Life Technologies
|
HealthFutures, LLC | |||
Details Procurement of the company's technology by the U.S. Government |
Immediate Response Technologies
|
KING & SPALDING LLP | |||
Details Briefings to member offices and Defense Committees on cost savings through the use of predictive modeling in complex systems |
Clockwork Solutions, Inc.
|
Command Strategies, LLC | |||
Details Appropriations Report language for start-up green technology companies. |
G.C. Barnes Group
|
Tauzin Consultants, LLC | |||
Details Lobbying related to innovation and competition in the life sciences sector |
Weil, Gotshal & Manges LLP (On behalf of NanoString Technologies, Inc.)
|
FGS Global (US) LLC (FKA FGH Holdings LLC) | |||
Details Improvements in life-cycle performance and cost prediction for complex government-owned assets and programs; FY 2013 National Defense Authorization Act |
Clockwork Solutions, Inc.
Total-life-cycle performance prediction and risk management solutions |
THE CHARLES GROUP, LLC | |||
Details Medicare coverage and reimbursement |
The McManus Group on behalf of Caris Life Sciences and Breathe Technologies Inc.
Government affairs consulting |
WALTER CONSULTING | |||
Details Providing assistance in securing federal funding to improve and develop new technologies for the blind and visually impaired persons needed for education and life. |
American Printing House for the Blind
|
Taylor Strategies | |||
Details -Issues relating to gene therapy, value-based arrangements, and the Patient Affordability, Value and Efficacy (PAVE) Act. -Implementation of the Orphan Drug Act of 1983 (P.L. 97-414) and orphan dru... |
Bluebird Bio
|
FOLEY HOAG LLP | |||
Details Issues related to fuel economy and emissions standards. Support for advanced engine, emission control and propulsion technology. Issues pertaining to air quality and emissions standards for light d... |
Alliance for Vehicle Efficiency
|
DYKEMA GOSSETT PLLC | |||
Details Issues related to the implementation of the FDA Medical Device User Fee Agreement (MDUFA) Issues related to establishing heart recovery as the standard of care Education on CMS coverage for breakt... |
ABIOMED, INC
|
in-house lobbying | |||
Details Extension of Section 420 and expansion to cover retiree life insurance |
ALCATEL-LUCENT, USA INC.
Telecommunications |
COVINGTON & BURLING LLP | |||
Details Precision medicine policies. Appropriate regulatory oversight of diagnostic testing, improved reimbursement of molecular testing, date of service regulation. Coverage and reimbursement of Next Gen... |
Caris Science, Inc.
Providing precision medicine diagnostic services to improve cancer care. |
Ernst & Young LLP (Washington Council Ernst & Young) | |||
Details Lobbying related to education on new and innovative agricultural technologies |
GreenLight Biosciences, Inc.
|
FGS Global (US) LLC (FKA FGH Holdings LLC) | |||
Details Issues related to coverage of medical devices Breakthrough technology designation associated with medicare reimbursement Issues related to diagnosis and treatment of structural heart disease Issues... |
Edwards Lifesciences
|
ALPINE GROUP, INC. | |||
Details DNA testing in general. H.R. 988/S. 517, Katie Sepich Enhanced DNA Collection Act of 2011. Laboratory testing in general. FDA regulations in general. NIH funding in general and effect of sequestr... |
LIFE TECHNOLOGIES CORPORATION
|
Peck Madigan Jones | |||
Details Lobbied on the importance of PBM transparency, oversight and reform on bills including S. 1339, the Pharmacy Benefit Manager Reform Act (on PBM issues overall and the inclusion of certain reporting... |
California Life Sciences
|
HAGGERTY POLICY SOLUTIONS | |||
Details Budget Appropriations |
Green World Resources
waste coal treatment |
GSP Consulting Corp | |||
Details Issues related to NHTSA fuel economy and emissions standards. Issues pertaining to EPA's Rulemaking for heavy duty Trucks and light duty vehicles Support for advanced engine, emission control, and ... |
Alliance for Vehicle Efficiency
|
Armitage Consulting, LLC | |||
Details General Education on Vaxess Technologies, Inc. Pandemic preparedness. |
Vaxess Technologies Inc.
|
Todd Strategy Group | |||
Details Banking related issues in appropriations bills and general banking issues |
US Bancorp
Bank |
RR&G, LLC | |||
Details Issues related to U.S. international tax law and OECD global minimum tax proposals |
Working Group on Competitive International Taxation (informal coalition)
|
Ernst & Young LLP (Washington Council Ernst & Young) | |||
Details IRA implementation, transparency, vaccines, coverage and access IRA implementation, supply chain integrity, 340B, orphan drugs, newborn screening, expanded access, transparency, drug shortages, dru... |
Sanofi US Services, Inc. (formerly known as Genzyme Corporation)
|
TARPLIN, DOWNS & YOUNG, LLC | |||
Details H.R. 2882, Further Consolidated Appropriations Act, 2024, Division F, Department of State, Foreign Operations, and Related Programs Appropriations Act, 2024, titles III and VII, all provisions rela... |
Population Action International
|
in-house lobbying | |||
Details 1. Educating policymakers on the costs vs. benefits of various approaches to regulations of GHGs, including: EPA actions to regulate GHGs under the Clean Air Act, as well as CEQ and other agencies... |
Western Business Roundtable
|
POLICY COMMUNICATONS, INC. | |||
Details Support the Modernizing Opiod Treatment Access Act (MOTA) - H.R. 1359, S. 644 Support OMB's Proposed Rule Guidance for Grants and Agreements, 87 Fed. Reg. 62218 (Oct. 13, 2022) which implements the... |
SHEET METAL & AIR CONDITIONING CONTRACTORS NAT'L ASSN
|
in-house lobbying | |||
Details Advocated for permanent adoption of the telehealth flexibilities created during the COVID-19 public health emergency Advocated for changes to the drug pricing provisions of the Inflation Reduction ... |
Biocom
|
in-house lobbying |